Effect of Dutasteride on the Risk of Prostate Cancer

20101,134 citationsJournal Articlebronze Open Access

Authors

Gerald L. Andriole · Washington University in St. Louis

David G. Bostwick · Bostwick Laboratories

Otis W. Brawley · American Cancer Society

Leonard G. Gomella · Sidney Kimmel Cancer Center

Michael Marberger · Medical University of Vienna

Francesco Montorsi · Vita-Salute San Raffaele University

Curtis A. Pettaway

Abstract

Over the course of the 4-year study period, dutasteride reduced the risk of incident prostate cancer detected on biopsy and improved the outcomes related to benign prostatic hyperplasia. (ClinicalTrials.gov number, NCT00056407.)

Topics & Keywords

Urinary Bladder and Prostate Research Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 362, Issue 13, pp. 1192-1202

DOI: 10.1056/nejmoa0908127

Field-Weighted Citation Impact: 133.56